Actually, I have stopped paying attention to VRUS from an investment standpoint because, as of about 3 weeks ago, I'm working professionally on HCV-related stuff.
I'm building a list of potentially interesting biotechs. But I'm not jumping in with both feet--all I've done is take my high-yield portfolio off the DRIP, and I'm using that money (plus whatever I put in from my job) to buy biotechs again.
So far I've been building another position in RPRX, and I've bought a significant amount of BVF.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.